2/26
11:26 am
anik
Anika Therapeutics Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
Anika Therapeutics Q4 Earnings Call Highlights [Yahoo! Finance]
2/26
07:32 am
anik
Anika Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Medium
Report
Anika Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
2/26
07:05 am
anik
Anika Reports Fourth Quarter and Full Year 2025 Financial Results
Medium
Report
Anika Reports Fourth Quarter and Full Year 2025 Financial Results
2/18
04:01 pm
anik
Anika To Present at the Canaccord Genuity 2026 Musculoskeletal Conference
Low
Report
Anika To Present at the Canaccord Genuity 2026 Musculoskeletal Conference
2/12
04:01 pm
anik
Anika to Issue Fourth Quarter and Year-End 2025 Financial Results on Thursday, February 26, 2026
Low
Report
Anika to Issue Fourth Quarter and Year-End 2025 Financial Results on Thursday, February 26, 2026
2/4
09:27 am
anik
Lumicell Appoints Biotech and Medtech Leader Cheryl R. Blanchard, Ph.D., to Board of Directors [Yahoo! Finance]
Medium
Report
Lumicell Appoints Biotech and Medtech Leader Cheryl R. Blanchard, Ph.D., to Board of Directors [Yahoo! Finance]
2/4
08:54 am
anik
Lumicell Appoints Biotech and Medtech Leader Cheryl R. Blanchard, Ph.D., to Board of Directors
Medium
Report
Lumicell Appoints Biotech and Medtech Leader Cheryl R. Blanchard, Ph.D., to Board of Directors
1/26
05:16 pm
anik
ANIKA INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Reminds Anika Therapeutics Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Anika Stockholders
Low
Report
ANIKA INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Reminds Anika Therapeutics Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Anika Stockholders
1/23
08:00 pm
anik
ANIK INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Anika Therapeutics, Inc.
Low
Report
ANIK INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Anika Therapeutics, Inc.
1/9
08:02 am
anik
Anika Therapeutics (NASDAQ:ANIK) had its "outperform" rating reaffirmed by analysts at Barrington Research. They now have a $16.00 price target on the stock.
Low
Report
Anika Therapeutics (NASDAQ:ANIK) had its "outperform" rating reaffirmed by analysts at Barrington Research. They now have a $16.00 price target on the stock.
1/8
07:05 pm
anik
Anika Therapeutics Announces Leadership Transition [Yahoo! Finance]
Low
Report
Anika Therapeutics Announces Leadership Transition [Yahoo! Finance]
1/8
07:00 am
anik
Anika Therapeutics Announces Leadership Transition
Low
Report
Anika Therapeutics Announces Leadership Transition
12/30
06:00 pm
anik
ANIK Investigation: Investors Encouraged to Contact Kirby McInerney LLP
Low
Report
ANIK Investigation: Investors Encouraged to Contact Kirby McInerney LLP
12/5
08:00 pm
anik
Anika Therapeutics, Inc. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors ANIK
Low
Report
Anika Therapeutics, Inc. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors ANIK
12/3
05:37 am
anik
Are Investors Undervaluing Anika Therapeutics, Inc. (NASDAQ:ANIK) By 39%? [Yahoo! Finance]
Low
Report
Are Investors Undervaluing Anika Therapeutics, Inc. (NASDAQ:ANIK) By 39%? [Yahoo! Finance]